2.59
price up icon3.19%   0.08
pre-market  Pre-market:  2.65   0.06   +2.32%
loading
Nkarta Inc stock is traded at $2.59, with a volume of 1.16M. It is up +3.19% in the last 24 hours and up +4.02% over the past month. Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
See More
Previous Close:
$2.51
Open:
$2.54
24h Volume:
1.16M
Relative Volume:
1.58
Market Cap:
$183.97M
Revenue:
-
Net Income/Loss:
$-117.50M
P/E Ratio:
-1.0792
EPS:
-2.4
Net Cash Flow:
$-114.31M
1W Performance:
+16.14%
1M Performance:
+4.02%
6M Performance:
+17.73%
1Y Performance:
+37.77%
1-Day Range:
Value
$2.53
$2.685
1-Week Range:
Value
$2.20
$2.685
52-Week Range:
Value
$1.31
$2.74

Nkarta Inc Stock (NKTX) Company Profile

Name
Name
Nkarta Inc
Name
Phone
(925) 407-1049
Name
Address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
Employee
157
Name
Twitter
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
NKTX's Discussions on Twitter

Compare NKTX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NKTX
Nkarta Inc
2.59 178.28M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.05 123.82B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
784.28 81.64B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
816.95 52.00B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.36 44.14B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
352.23 40.83B 4.98B 69.60M 525.67M 0.5198

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-25 Downgrade William Blair Outperform → Mkt Perform
Oct-09-24 Initiated Rodman & Renshaw Buy
Aug-14-24 Upgrade Raymond James Outperform → Strong Buy
Mar-22-24 Downgrade Raymond James Strong Buy → Outperform
Dec-22-22 Downgrade Oppenheimer Outperform → Perform
Oct-10-22 Initiated Canaccord Genuity Buy
Jul-28-22 Initiated Needham Buy
Jul-18-22 Initiated SVB Leerink Outperform
Mar-11-22 Initiated Raymond James Outperform
Mar-08-22 Initiated H.C. Wainwright Buy
Jan-06-22 Initiated William Blair Outperform
Nov-18-21 Initiated SMBC Nikko Outperform
Jul-16-21 Initiated Oppenheimer Outperform
Aug-04-20 Initiated Cowen Outperform
Aug-04-20 Initiated Evercore ISI Outperform
Aug-04-20 Initiated Mizuho Buy
Aug-04-20 Initiated Stifel Buy
View All

Nkarta Inc Stock (NKTX) Latest News

pulisher
Feb 24, 2026

Profit Review: Does Nkarta Inc have declining or rising EPSWeekly Trade Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 20, 2026

Why analysts upgrade Nkarta Inc. stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 17, 2026

Death Cross: Will Nkarta Inc stock benefit from M AJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Feb 17, 2026
pulisher
Feb 16, 2026

How buybacks impact Nkarta Inc. stock valueShort Setup & Weekly Sector Rotation Insights - mfd.ru

Feb 16, 2026
pulisher
Feb 15, 2026

Nkarta, Inc. (NASDAQ:NKTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 15, 2026
pulisher
Feb 14, 2026

Is Nkarta Inc. stock dividend yield sustainable2025 Biggest Moves & Safe Entry Zone Identification - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

What is Nkarta Inc.’s book value per shareDividend Hike & Low Drawdown Trading Techniques - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

What dividend growth rate does Nkarta Inc offer2025 Geopolitical Influence & Fast Moving Stock Watchlists - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 13, 2026

Nkarta (NASDAQ:NKTX) Stock Price Down 1.5%What's Next? - MarketBeat

Feb 13, 2026
pulisher
Feb 12, 2026

How sensitive is Nkarta Inc. to inflation2025 Risk Factors & Verified Momentum Stock Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

What dividend growth rate does Nkarta Inc. offer2025 Year in Review & Consistent Growth Equity Picks - mfd.ru

Feb 11, 2026
pulisher
Jan 28, 2026

Sentiment Review: Can Nkarta Inc be the next market leaderWeekly Investment Summary & Reliable Price Breakout Signals - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 28, 2026

Aug Macro: What is the earnings history of Workiva IncDividend Hike & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 23, 2026

Nkarta Insiders Make Handsome Sum Selling Stock At US$2.06 Per Share - simplywall.st

Jan 23, 2026
pulisher
Jan 21, 2026

Nkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Nkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

Jan 21, 2026
pulisher
Jan 20, 2026

Nkarta CEO Hastings sells $53,915 in NKTX stock By Investing.com - Investing.com South Africa

Jan 20, 2026
pulisher
Jan 20, 2026

Insider Selling: Nkarta (NASDAQ:NKTX) CEO Sells 26,046 Shares of Stock - MarketBeat

Jan 20, 2026
pulisher
Jan 20, 2026

Insider Selling: Nkarta (NASDAQ:NKTX) President Sells 5,649 Shares of Stock - MarketBeat

Jan 20, 2026
pulisher
Jan 20, 2026

Nkarta (NKTX) president Nadir sells $11,693 in shares - Investing.com

Jan 20, 2026
pulisher
Jan 20, 2026

Nkarta CEO Hastings sells $53,915 in NKTX stock - Investing.com

Jan 20, 2026
pulisher
Jan 19, 2026

Growth Value: Is Valens Semiconductor Ltd forming a bullish divergenceMarket Movement Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 19, 2026

Can Nkarta Inc. stock double in next 5 yearsAnalyst Upgrade & Entry Point Confirmation Alerts - Bollywood Helpline

Jan 19, 2026
pulisher
Jan 15, 2026

Nkarta, Inc. (NASDAQ:NKTX) Short Interest Update - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

How do insiders feel about Nkarta IncMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

Aug Update: Does Nkarta Inc align with a passive investing strategyJuly 2025 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

RSI Check: Will Nkarta Inc stock benefit from commodity pricesSell Signal & AI Enhanced Trading Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Aug Weekly: Can Nkarta Inc stock outperform in 2025 bull marketJuly 2025 Trade Ideas & Free Reliable Trade Execution Plans - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Aug Action: Why Nkarta Inc. stock is favored by top institutionsPortfolio Risk Summary & Low Risk High Win Rate Picks - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 09, 2026

Rate Hike: Does Nkarta Inc stock trade at a discount to peersJuly 2025 Update & Expert-Curated Trade Recommendations - Bộ Nội Vụ

Jan 09, 2026
pulisher
Jan 08, 2026

Is Nkarta Inc. stock affected by interest rate hikesEarnings Growth Summary & Stock Portfolio Risk Management - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Nkarta Inc. stock supported by strong cash flows2025 Volume Leaders & Verified Swing Trading Watchlists - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Nkarta Inc. stock attractive for passive investors2025 Major Catalysts & Precise Buy Zone Identification - Улправда

Jan 08, 2026
pulisher
Jan 05, 2026

Fat Pitch FinancialsNkarta, Inc.Common Stock (Nasdaq:NKTX) Stock Quote - FinancialContent

Jan 05, 2026
pulisher
Dec 31, 2025

The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals

Dec 31, 2025
pulisher
Dec 27, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 27, 2025
pulisher
Dec 27, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Dec 27, 2025
pulisher
Dec 25, 2025

Analysts’ Recent Ratings Updates for Nkarta (NKTX) - Defense World

Dec 25, 2025
pulisher
Dec 20, 2025

Nkarta Shares Show Signs of Finding a Floor - AD HOC NEWS

Dec 20, 2025
pulisher
Dec 20, 2025

How strong is Nkarta Inc. stock balance sheetJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Nkarta Inc. stock is favored by top institutions2025 Volume Leaders & Daily Technical Stock Forecast Reports - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Portfolio Recap: Is Nkarta Inc. stock attractive for growth ETFsJuly 2025 Action & Fast Gain Stock Tips - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Nkarta (NASDAQ:NKTX) Rating Increased to Hold at Wall Street Zen - Defense World

Dec 20, 2025
pulisher
Dec 19, 2025

Is Nkarta Inc. stock a safe buy before earningsJuly 2025 Price Swings & Weekly Stock Breakout Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Nkarta, Inc.(NasdaqGS: NKTX) dropped from NASDAQ Biotechnology Index - marketscreener.com

Dec 18, 2025
pulisher
Dec 16, 2025

What analysts say about Nkarta Inc stockPortfolio Diversification Tips & High Profit Trading Alerts - earlytimes.in

Dec 16, 2025
pulisher
Dec 13, 2025

Nkarta, Inc. $NKTX Shares Sold by AWM Investment Company Inc. - Defense World

Dec 13, 2025
pulisher
Dec 11, 2025

This trade activity should not be overlooked: Nkarta Inc (NKTX) - setenews.com

Dec 11, 2025
pulisher
Dec 07, 2025

VIX Spike: Why analysts upgrade STVN stockWeekly Market Report & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 07, 2025

Nkarta (NASDAQ:NKTX) Downgraded by Wall Street Zen to Sell - MarketBeat

Dec 07, 2025
pulisher
Dec 04, 2025

Nkarta Inc (NKTX) Performance and Fundamentals Dashboard tells a completely different story - setenews.com

Dec 04, 2025

Nkarta Inc Stock (NKTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$103.24
price down icon 1.52%
$51.37
price up icon 1.68%
$28.66
price up icon 1.42%
$109.84
price down icon 0.94%
$148.61
price down icon 6.31%
biotechnology ONC
$352.23
price down icon 4.54%
Cap:     |  Volume (24h):